BRIEF published on 06/24/2024 at 14:37, 2 years 2 months ago Nakiki SE: Preliminary Financial Results for 2022 and 2023 2023 Preliminary Results Insolvency NAKIKI SE 2022
PRESS RELEASE published on 06/24/2024 at 14:32, 2 years 2 months ago EQS-Adhoc: Nakiki SE: Preliminary results for 2022 and 2023 Nakiki SE announces preliminary results for 2022 and 2023. Company was in insolvency in 2023 and now debt-free. Figures relate to former business, not current operations Preliminary Results Insolvency Proceedings NAKIKI SE Debt-Free Financial Years
BRIEF published on 06/20/2024 at 17:55, 2 years 3 months ago Nakiki SE Reaches EUR 1.26 Million Settlement 2024 NAKIKI SE Legal Finance Settlement EUR 1.26 Million
PRESS RELEASE published on 06/20/2024 at 17:50, 2 years 3 months ago EQS-Adhoc: Nakiki SE: Settlement of EUR 1.26 million Nakiki SE settles lawsuit for EUR 1.26 million financed by a subsidiary. Legal Finance entitled to 50% of settlement amount. Payment expected by year-end Lawsuit NAKIKI SE Legal Finance Settlement EUR 1.26 Million
BRIEF published on 05/29/2024 at 06:51, 2 years 3 months ago Nakiki SE Secures EUR 3 Million in New Litigation Financing Agreements Real Estate Business Loans NAKIKI SE Litigation Financing Legal Claims
PRESS RELEASE published on 05/29/2024 at 06:46, 2 years 3 months ago EQS-Adhoc: Nakiki SE: New litigation financing agreements: EUR 3 million, option volume EUR 1.5 million Nakiki SE announces EUR 3 million new litigation financing agreements. Cases include real estate, car accident, and loan disputes. Total in dispute: EUR 3.5 million NAKIKI SE Litigation Financing Legal Finance New Agreements Dispute Amount
BRIEF published on 05/22/2024 at 15:30, 2 years 3 months ago Andreas Wegerich Appointed New CEO of Nakiki SE Executive Board Appointment CEO NAKIKI SE Andreas Wegerich
PRESS RELEASE published on 05/22/2024 at 15:25, 2 years 3 months ago EQS-Adhoc: Nakiki SE: Andreas Wegerich appointed new Chief Executive Officer of Nakiki SE Andreas Wegerich appointed new Chief Executive Officer of Nakiki SE. The Supervisory Board's decision to name him CEO is part of a strategic leadership change CEO Appointment Executive Board Leadership Change NAKIKI SE Andreas Wegerich
BRIEF published on 05/09/2024 at 12:07, 2 years 4 months ago Nakiki SE Evaluates EUR 30 Million Claim from COVID Mask Supplies COVID-19 Germany NAKIKI SE Litigation Financing Mask Supply
PRESS RELEASE published on 05/09/2024 at 12:02, 2 years 4 months ago EQS-Adhoc: Nakiki SE: Review of a potential claim of approximately EUR 30 million Nakiki SE reviews potential claim of EUR 30 million related to COVID mask supply during pandemic, with an option volume of up to EUR 15 million. Legal Finance Holding SE examines the case NAKIKI SE Litigation Financing Legal Finance Potential Claim COVID Masks
Published on 09/21/2026 at 15:45, 4 hours 42 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 6 hours 7 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 6 hours 22 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 6 hours 27 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 6 hours 42 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 18:00, 2 hours 27 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 2 hours 42 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 2 hours 42 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 3 hours 27 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 2 hours 8 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 2 hours 25 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 2 hours 41 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 13 hours 27 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
